First Opinion - Page 2 of 67

First Opinion

An ‘America first’ pharma supply chain sounds good. But it won’t work

By Michael Rea

First Opinion

Cough and pneumonia in the time of coronavirus

By Amy Sarah Ginsburg

First Opinion

To fight Covid-19, open access to scientific publishing

By Peter Walter and R. Dyche Mullins

First Opinion

By phone, cancer patients reveal their Covid-19 angst — and seek help

By Alissa Gentile and Meredith Barnhart

First Opinion

Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’

By Patricia Deverka, Louis Garrison, and Samuel Nussbaum

First Opinion

Fee for service is a terrible way to pay for health care. Try a subscription model instead

By Vivian S. Lee

First Opinion

Dearth of disability-related Covid-19 data can confound response efforts

By Bonnielin Swenor

First Opinion

What being stricken with Covid-19 taught a biotech CEO

By Cedric François

First Opinion

A pandemic, a funeral, and a chance to help heal the world

By Michelle McMurry-Heath

First Opinion

Collective intelligence, not market competition, will deliver the best Covid-19 vaccine

By Els Torreele

First Opinion

A national registry could help defeat sepsis, a big contributor to Covid-19 deaths

By Steven Q. Simpson, Karin H. Molander, and Rommie Duckworth

First Opinion

To allocate remdesivir fairly, give it to communities that bear a disproportionate burden of Covid-19

By Parker Crutchfield, Tyler S. Gibb, and Michael Redinger

First Opinion

The Bio Revolution is changing business and society

By Matthias Evers and Michael Chui

First Opinion

Beyond words: medical institutions must act to support Black lives

By Carrie Flynn and Chinye Ijeli

First Opinion

Contact tracing technology must protect people from discrimination as well as disease

By Pardis Sabeti and Andres Colubri

First Opinion

Covid-19 is changing the game for health care companies and investors

By Eric M. Stone

First Opinion

Police brutality is our lane too, doctors say

By Chijioke Nze, Elorm F. Avakame, Olusola J. Ayankola, and Jamaji C. Nwanaji-Enwerem

First Opinion

Racism: The contagion in health care we need to eradicate

By David Malebranche

First Opinion

Oxford, AstraZeneca Covid-19 deal reinforces ‘vaccine sovereignty.’ We need a people’s vaccine instead

By A. Kayum Ahmed

First Opinion

Create a health impact fund to spur development and equitable use of a Covid-19 vaccine

By Aidan Hollis

First Opinion

It’s time to bring generic drug manufacturing back to the U.S.

By Peter Kolchinsky

First Opinion

Covid-19 has exposed cracks in the global medicines supply chain. We need to fix them

By Anthony Lakavage

First Opinion

Optimism, not evidence, is driving America’s return-to-work strategy

By Rajaie Batniji

First Opinion

My nightmare: Covid-19 meets racism meets the killing of a Black person by police

By Lauren Powell

First Opinion

Cutting ties with WHO creates a scientific and leadership vacuum

By Ashish K. Jha

The Trump rally in Tulsa is a recipe for disaster

Account for gender/sex to make personal protective equipment safer for women

How many needless Covid-19 deaths were caused by delays in responding? Most of them

Scientists as heroes: Let’s keep that image in the public eye

An ‘America first’ pharma supply chain sounds good. But it won’t work

Cough and pneumonia in the time of coronavirus

To fight Covid-19, open access to scientific publishing

By phone, cancer patients reveal their Covid-19 angst — and seek help

Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’

Fee for service is a terrible way to pay for health care. Try a subscription model instead

Dearth of disability-related Covid-19 data can confound response efforts

What being stricken with Covid-19 taught a biotech CEO

A pandemic, a funeral, and a chance to help heal the world

Collective intelligence, not market competition, will deliver the best Covid-19 vaccine

A national registry could help defeat sepsis, a big contributor to Covid-19 deaths

To allocate remdesivir fairly, give it to communities that bear a disproportionate burden of Covid-19

The Bio Revolution is changing business and society

Beyond words: medical institutions must act to support Black lives

Contact tracing technology must protect people from discrimination as well as disease

Covid-19 is changing the game for health care companies and investors

Police brutality is our lane too, doctors say

Racism: The contagion in health care we need to eradicate

Oxford, AstraZeneca Covid-19 deal reinforces ‘vaccine sovereignty.’ We need a people’s vaccine instead

Create a health impact fund to spur development and equitable use of a Covid-19 vaccine

It’s time to bring generic drug manufacturing back to the U.S.

Covid-19 has exposed cracks in the global medicines supply chain. We need to fix them

Optimism, not evidence, is driving America’s return-to-work strategy

My nightmare: Covid-19 meets racism meets the killing of a Black person by police

Cutting ties with WHO creates a scientific and leadership vacuum